Nitric Oxide Battles Tuberculosis | December 1, 2008 Issue - Vol. 86 Issue 48 | Chemical & Engineering News
Volume 86 Issue 48 | p. 51 | Concentrates
Issue Date: December 1, 2008

Nitric Oxide Battles Tuberculosis

Experimental drugs release NO, which kills dormant as well as active tuberculosis cells
Department: Science & Technology

A promising class of experimental bicyclic nitroimidazole drugs kills tuberculosis bacteria by unleashing lethal nitric oxide inside the cells, according to a report in Science (2008, 322, 1392). Release of the highly reactive NO is "akin to a bomb blast that kills the bacteria from within," says Clifton E. Barry III of the National Institute of Allergy & Infectious Diseases, in Bethesda, Md. Barry and his colleagues found that an enzyme in the tuberculosis bacterium metabolizes drug candidates such as PA-824, in the process releasing nitrous acid, which in turn forms NO. PA-824 and a second bicyclic nitroimidazole known as OPC-67683 are now in human clinical trials. The compounds are attractive because they kill both replicating and nonreplicating tuberculosis bacteria. Researchers suspect that conventional treatment for the disease takes at least six months because it largely fails to kill nonreplicating bacteria.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment